Gene · 10801
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PCR and molecular diagnostics: Biotechnologic integration in clinical laboratories. | Clin Chim Acta | 2027 | 42586250 | PubTator, text mining | PubMed |
| Evaluating circulating tumor DNA methylation patterns of a multi-gene panel for colorectal cancer diagnosis: A pilot study. | Clin Chim Acta | 2027 | 42320666 | PubTator, text mining | PubMed |
| Molecular biomarkers for early-stage hepatocellular carcinoma: Clinical applications beyond alpha-fetoprotein. | Int J Biol Markers | 2026 | 42777092 | PubTator, text mining | PubMed |
| A multidimensional integrated diagnostic strategy using needle sheath flushing solution: combining PGM-based GPC3 protein detection and gene methylation analysis for improved liver cancer diagnosis. | Anal Methods | 2026 | 42765306 | PubTator, text mining | PubMed |
| Quantitative SEPT9 Methylation in Colorectal and Endometrial Cancers Suspected of Lynch Syndrome. | Curr Mol Med | 2026 | 42764742 | PubTator, text mining | PubMed |
| SEPTIN9 R106W in a Chinese family with hereditary neuralgic amyotrophy: phenotypic heterogeneity and rehabilitation in a pediatric case. | Front Genet | 2026 | 42644177 | PubTator, text mining | PubMed |
| Silencing of SEPT9 inhibits proliferation and migration of endometriotic stromal cells via suppression of the PI3K/AKT signaling pathway. | Rev Invest Clin | 2026 | 42607562 | PubTator, text mining | PubMed |
| The TCN1 Paradox: Unraveling the Dual Role of Transcobalamin I in Colorectal Cancer-From Metabolic Regulation to Oncogenic Signaling. | Cancer Manag Res | 2026 | 42577958 | PubTator, text mining | PubMed |
| SEPTIN9 Gene Methylation Ratio as Follow-Up Biomarker in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. | J Surg Oncol | 2026 | 42523038 | PubTator, text mining | PubMed |
| Prospective evaluation of a multi-gene cfDNA methylation assay for colorectal cancer screening in a high-risk cohort. | Clin Chem Lab Med | 2026 | 42517221 | PubTator, text mining | PubMed |
| DNA Methylation and mRNA Expression of SEPT9 and AKR1B1 in Ovarian Cancer: Diagnostic and Prognostic Implications. | Int J Mol Sci | 2026 | 42511679 | PubTator, text mining | PubMed |
| Impact of Helicobacter pylori Infection Status on SEPTIN9 and SDC2 Methylation Levels and Their Association with Clinical Outcomes in Elderly Patients with Gastric Mucosal Intestinal Metaplasia. | Turk J Gastroenterol | 2026 | 42504675 | PubTator, text mining | PubMed |
| Early prediction of minimal residual disease in colorectal cancer via SEPTIN9 methylation status in circulating tumor DNA. | Ann Med | 2026 | 42464785 | PubTator, text mining | PubMed |
| Signal logic gate mediated by a controllable CRISPR/Cas12a system for simultaneous detection of DNA mutation and methylation. | Anal Methods | 2026 | 42459132 | PubTator, text mining | PubMed |
| In Silico Identification of Conserved 'Fungal Islands' in Human Septin9: Evidence for Atavistic Therapeutic Targets. | Int J Mol Sci | 2026 | 42450016 | PubTator, text mining | PubMed |
| Translational Validation of a Novel Multi-Locus ctDNA Methylation Assay for Early Detection and Stratification of Colorectal Cancer: An Exploratory Prospective, Case-Control Study. | Int J Mol Sci | 2026 | 42450011 | PubTator, text mining | PubMed |
| A Combination of Variants in SEPTIN9 and MSX1 Genes Leads to the Formation of Orofacial Clefts. | Genes Cells | 2026 | 42429105 | PubTator, text mining | PubMed |
| MIR133B-SEPT9 axis suppresses colorectal cancer progression by inhibiting β-catenin-mediated EMT signaling and is associated with poor prognosis. | Mol Med | 2026 | 42410499 | PubTator, text mining | PubMed |
| Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in Cirrhosis. | JAMA Oncol | 2026 | 42390849 | PubTator, text mining | PubMed |
| Uncovering alterations in cancer epigenetics via trans-dimensional Markov chain Monte Carlo and hidden Markov models. | J R Stat Soc Ser C Appl Stat | 2026 | 42389235 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10801/papers